TrialThe journal of headache and pain2022

Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients.

Takao Takeshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.